Test-retest reliable and site-robust Hidden Markov Model framework for discovering whole-brain beta activity

preprint OA: closed
Full text JSON View at publisher

Abstract

Sensorimotor beta activity (13-30 Hz) is a key neuronal signature in the human sensorimotor system, and its features can be effectively measured using functional brain imaging methods such as magnetoencephalography (MEG). In addition to its importance in healthy brain processing, beta activity has been shown to be altered in several neurological diseases, underscoring its potential as a biomarker. To serve as biomarkers, features must be reliably defined, stable across measurements and, ideally, amenable to automated analysis, yet current approaches to beta characterization require subjective decisions and manual work. We here describe a hidden Markov model (HMM) based approach to automatically segment beta events from source level MEG beta band activity into discrete high- and low-beta states. We demonstrate the differences between the proposed HMM based approach and a commonly used amplitude-envelope based approach to analyse high- and low-beta modulation. We show that the methods complement each other both when applied to resting data and task related passive movement data. Furthermore, we assess the test-retest reliability of the proposed pipeline within individuals using intraclass correlation coefficients (ICC), and test if HMM constructed at one measurement site can be applied to data acquired at another site, thereby evaluating its multisite transferability. We show that the proposed approach produces stable results within subjects and across sites for many of the features. The ICC values were excellent for high-beta state (86-100% of brain areas), while low-beta state test-retest reliability was more modest. Most of the features showed statistically significant differences between sites only in a few brain areas, indicating very good multisite stability. The proposed approach can serve as an automated, reproducible analysis pipeline for, e.g., clinical applications, and appears suitable for multi-site datasets.
Full text 2,556 characters · extracted from oa-doi-fallback · click to expand
Abstract Sensorimotor beta activity (13-30 Hz) is a key neuronal signature in the human sensorimotor system, and its features can be effectively measured using functional brain imaging methods such as magnetoencephalography (MEG). In addition to its importance in healthy brain processing, beta activity has been shown to be altered in several neurological diseases, underscoring its potential as a biomarker. To serve as biomarkers, features must be reliably defined, stable across measurements and, ideally, amenable to automated analysis, yet current approaches to beta characterization require subjective decisions and manual work. We here describe a hidden Markov model (HMM) based approach to automatically segment beta events from source level MEG beta band activity into discrete high- and low-beta states. We demonstrate the differences between the proposed HMM based approach and a commonly used amplitude-envelope based approach to analyse high- and low-beta modulation. We show that the methods complement each other both when applied to resting data and task related passive movement data. Furthermore, we assess the test-retest reliability of the proposed pipeline within individuals using intraclass correlation coefficients (ICC), and test if HMM constructed at one measurement site can be applied to data acquired at another site, thereby evaluating its multisite transferability. We show that the proposed approach produces stable results within subjects and across sites for many of the features. The ICC values were excellent for high-beta state (86-100% of brain areas), while low-beta state test-retest reliability was more modest. Most of the features showed statistically significant differences between sites only in a few brain areas, indicating very good multisite stability. The proposed approach can serve as an automated, reproducible analysis pipeline for, e.g., clinical applications, and appears suitable for multi-site datasets. Competing Interest Statement The authors have declared no competing interest. Footnotes Author roles SK: conceptualization, formal analysis, data curation, methodology, software, visualization, writing-original draft preparation CA: methodology, writing – review & editing ML: data curation, investigation, writing – review & editing DV: methodology, writing – review & editing HR: investigation, resources, writing – review & editing AP: conceptualization, methodology, investigation, funding acquisition, project administration, supervision, visualization, writing-original draft preparation

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-07-21T06:50:27.635823+00:00